Study in Patients' With Persistent Asthma and Chronic Obstructive Pulmonary Disease

Inclusion Criteria: * Patient ≥ 18 years of age who has been diagnosed with persistent asthma or patient ≥ 40 years of age and/or (ex)-smoker with more than 10 pack years of smoking who has been diagnosed with COPD * Treatment with a stable dose (no change in dose or change by less than 50% in the last 3 months) of a Inhaled corticosteroid (ICS), Long-acting beta2-agonists (LABA), Fixed dose combination (FDC) administered twice daily by Dry powder inhaler (DPI) for 3 months prior to enrollment in accordance with its approved indication * Patient is willing and able to provide written informed consent; * Patient agrees to participate in the study and to disclose any medical events to the treating physician; * Patient is able to complete the questionnaires. Exclusion Criteria: • Current enrolment or planned enrolment in an interventional study (patients are allowed to participate in other observational or case-control studies).